14th week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200101120 | LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT | 2020-04-02 |
20200101121 | METHODS AND PROBIOTIC COMPOSITIONS FOR THE TREATMENT OF BONE DISORDERS | 2020-04-02 |
20200101122 | METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER | 2020-04-02 |
20200101123 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS, DISORDERS, AND DISEASES OF THE SKIN | 2020-04-02 |
20200101124 | AQUEOUS EXTRACTS OF ERUCA SATIVA LEAVES AND METHODS FOR INHIBITING GROWTH OF GRAM-POSITIVE BACTERIA AND MYCOPLASMA | 2020-04-02 |
20200101125 | EXTRACT OF VICIA FABA BEANS | 2020-04-02 |
20200101126 | AQUEOUS EXTRACTION PROCESS OF PLANTS, METHOD THEREOF, AND PRODUCT BY PROCESS | 2020-04-02 |
20200101127 | COMPOSITIONS COMPRISING EXTRACT OF POPLAR BUDS AND USES THEREOF | 2020-04-02 |
20200101128 | COMPOSITION, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF IN THE PREVENTION AND TREATMENT OF MAMMARY GLAND DISEASE | 2020-04-02 |
20200101129 | METHOD FOR PROCESSING RAW SUGARCANE MAXIMIZING THE PRESERVATION OF POLICOSANOLS DURING PRODUCTION OF A NATURAL SUGARCANE JUICE-BASED PRODUCT | 2020-04-02 |
20200101130 | NOVEL-ANTI-INFECTIVE STRATEGY AGAINST INFLUENZA VIRUS AND S. AUREUS COINFECTIONS | 2020-04-02 |
20200101131 | METHOD FOR TREATING CANCER | 2020-04-02 |
20200101132 | COMPOUNDS AND METHODS FOR INCREASING HAIR GROWTH | 2020-04-02 |
20200101133 | METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS | 2020-04-02 |
20200101134 | METHODS FOR TREATING MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS AND ANEMIA | 2020-04-02 |
20200101135 | MUSSEL ADHESIVE PROTEIN PRODUCT AND USE THEREOF FOR TREATING MUCOSAL INFLAMMATION | 2020-04-02 |
20200101136 | COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS | 2020-04-02 |
20200101137 | METHODS OF TREATING METABOLIC DISORDERS ASSOCIATED WITH LIPODYSTROPHIES AND DEFECTS IN INSULIN PRODUCTION OR SIGNALING | 2020-04-02 |
20200101138 | GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS | 2020-04-02 |
20200101139 | MEDICAMENT FOR MITIGATING CONDITIONS AND/OR SUPPRESSING ONSET OF PERIPHERAL NEUROPATHY INDUCED BY ANTI-MALIGNANT TUMOR AGENT | 2020-04-02 |
20200101140 | ADENO-ASSOCIATED VIRUS FACTOR VIII VECTORS | 2020-04-02 |
20200101141 | METHODS FOR TREATING HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS | 2020-04-02 |
20200101142 | PDE5 COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | 2020-04-02 |
20200101143 | COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER | 2020-04-02 |
20200101144 | SUBCUTANEOUS ADMINISTRATION OF ADAMTS13 | 2020-04-02 |
20200101145 | COMPOSITIONS FOR TREATING ADDICTION | 2020-04-02 |
20200101146 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE | 2020-04-02 |
20200101147 | POLYPEPTIDE VACCINE | 2020-04-02 |
20200101148 | H3.3 CTL Peptides and Uses Thereof | 2020-04-02 |
20200101149 | CELLULAR ADJUVANTS FOR VIRAL INFECTION | 2020-04-02 |
20200101150 | Dengue Virus Specific Multiple HLA Binding T Cell Epitopes For The Use Of Universal Vaccine Development | 2020-04-02 |
20200101151 | VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY | 2020-04-02 |
20200101152 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING HIV | 2020-04-02 |
20200101153 | MVA-BN AND AD26.ZEBOV OR AD26.FILO PRIME-BOOST REGIMEN | 2020-04-02 |
20200101154 | TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS | 2020-04-02 |
20200101155 | TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS | 2020-04-02 |
20200101156 | ADOPTIVE CELL THERAPY USING SPHERICAL NUCLEIC ACIDS (SNAS) | 2020-04-02 |
20200101157 | VITRO CELL CULTURE METHODS FOR BETA-THALASSEMIA USING ACTIVIN TYPE II RECEPTOR LIGAND TRAPS | 2020-04-02 |
20200101158 | ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF | 2020-04-02 |
20200101159 | TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT | 2020-04-02 |
20200101160 | METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY | 2020-04-02 |
20200101161 | Photosensitive Dyes and Method of Using Said Dyes | 2020-04-02 |
20200101162 | EXENATIDE MODIFIER AND USE THEREOF | 2020-04-02 |
20200101163 | COMPOSITIONS COMPRISING BIODEGRADABLE COPOLYMERS | 2020-04-02 |
20200101164 | COSMETIC AND PHARMACEUTICAL FOAM | 2020-04-02 |
20200101165 | COMPOSITE CONTAINING POLY(GLYCEROL SEBACATE) FILLER | 2020-04-02 |
20200101167 | EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS | 2020-04-02 |
20200101168 | PROCESS FOR PREPARING CELL-BINDING AGENT-CYTOTOXIC AGENT CONJUGATES | 2020-04-02 |
20200101169 | ANTIGEN-SPECIFIC TOLERANCE AND COMPOSITIONS FOR INDUCTION OF SAME | 2020-04-02 |
20200101170 | IMMUNOPARTICLES AND METHODS OF GENERATING AND USING SAME | 2020-04-02 |
20200101171 | INSULIN ANALOG COMPLEX WITH REDUCED AFFINITY FOR INSULIN RECEPTOR AND USE THEREOF | 2020-04-02 |
20200101172 | GUIDE RNA MOLECULE AND METHOD FOR TREATING CANCER | 2020-04-02 |
20200101173 | Genome Editing System For Repeat Expansion Mutation | 2020-04-02 |
20200101174 | METHODS AND COMPOSITIONS FOR TREATING A PREMATURE STOP CODON-MEDIATED DISORDER | 2020-04-02 |
20200101175 | PHARMACEUTICAL COMPOSITION FOR INHALATION ADMINISTRATION TO LABELING PULMONARY NODULES COMPRISING FLUORESCENT CONTRAST AGENT AS AN ACTIVE INGREDIENT | 2020-04-02 |
20200101176 | Small Highly Uniform Nanomedicine Compositions for Therapeutic, Imaging and Theranostic Applications | 2020-04-02 |
20200101177 | MAGNETIC NANOCOMPOSITE COMPOSITIONS | 2020-04-02 |
20200101178 | Methods And Compositions For Targeted Imaging | 2020-04-02 |
20200101179 | DEVELOPMENT AND APPLICATION OF TUMOR DIAGNOSTIC RADIOACTIVE PROBE TARGETING FOLIC ACID RECEPTOR | 2020-04-02 |
20200101180 | ULTRASMALL NANOPARTICLES LABELED WITH ZIRCONIUM-89 AND METHODS THEREOF | 2020-04-02 |
20200101181 | ELECTROCHEMICAL PAPER TOWEL STERILIZING DEVICE | 2020-04-02 |
20200101182 | METHODS FOR INACTIVATING, ON MEDICAL INSTRUMENTS AND DEVICES, VIRUSES CONTAINING RNA AND DNA, AND APPARATUSES FOR IMPLEMENTATING SAME | 2020-04-02 |
20200101183 | SYSTEM AND METHOD FOR STERILIZATION USING ULTRA-VIOLET ILLUMINATION | 2020-04-02 |
20200101184 | Towel Disinfectant Apparatus | 2020-04-02 |
20200101185 | A METHOD FOR DISINFECTION AND CLEANING OF AT LEAST ONE PART OF A DEVICE INTENDED FOR RECYCLING OF WATER | 2020-04-02 |
20200101186 | STERILISATION METHOD | 2020-04-02 |
20200101187 | INFECTION CONTROL ATTACHMENT FOR STETHOSCOPES | 2020-04-02 |
20200101188 | CHALLENGE DEVICE FOR USE WITH A MEASURING UNIT FOR TESTING STEAM STERILIZATION EFFICIENCY AND A METHOD OF MANUFACTURE OF A CHALLENGE DEVICE | 2020-04-02 |
20200101189 | DEVICE AND METHOD FOR CONTROLLING SCENT | 2020-04-02 |
20200101190 | ELECTRONICALLY-ACTIVATED, SELF-MOLDING AND RE-SHAPEABLE LOAD-BEARING SUPPORT STRUCTURE SYSTEM AND METHODS FOR MOLDING THEREOF | 2020-04-02 |
20200101191 | HYDROENTANGLED FIBROUS STRUCTURES | 2020-04-02 |
20200101192 | WOUND DRESSING | 2020-04-02 |
20200101193 | IMPLANT AND METHOD OF PRODUCTION THEREOF | 2020-04-02 |
20200101194 | HYDROGEL COMPOSITION AND BIOINK COMPOSITION INCLUDING THE SAME | 2020-04-02 |
20200101195 | VASCULAR GRAFTS DERIVED FROM ACELLULAR TISSUE MATRICES | 2020-04-02 |
20200101196 | Cancellous Bone Product Including Viable Osteogenic Cells | 2020-04-02 |
20200101197 | MALLEABLE DEMINERALIZED BONE COMPOSITION AND METHOD OF MANUFACTURE | 2020-04-02 |
20200101198 | OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM | 2020-04-02 |
20200101199 | Biomaterial for Suturing | 2020-04-02 |
20200101200 | CORNEAL ENDOTHELIAL CELL MARKER AND USE THEREOF | 2020-04-02 |
20200101201 | BIOMATERIALS FOR ENHANCED IMPLANT-HOST INTEGRATION | 2020-04-02 |
20200101202 | STRETCHABLE NANOCOMPOSITE SKIN MATERIAL AND RELATED STRUCTURES | 2020-04-02 |
20200101203 | SPRAYABLE BARRIER AND METHODS FOR PREVENTION OF POSTOPERATIVE ADHESIONS | 2020-04-02 |
20200101204 | MEDICAL DEVICES | 2020-04-02 |
20200101205 | FLUID EXTRACTION DEVICE, APPLICATOR DEVICE AND ASSOCIATED METHODS | 2020-04-02 |
20200101206 | COMBINED LIPOSUCTION METHOD | 2020-04-02 |
20200101207 | SUSTAINED VARIABLE NEGATIVE PRESSURE WOUND TREATMENT AND METHOD OF CONTROLLING SAME | 2020-04-02 |
20200101208 | MECHANICAL WOUND THERAPY FOR SUB-ATMOSPHERIC WOUND CARE SYSTEM | 2020-04-02 |
20200101209 | MAP ESTIMATION ON VAD PATIENTS | 2020-04-02 |
20200101210 | DEVICES, SYSTEMS, AND METHODS FOR IMPLANTING AND USING A CONNECTOR IN A TISSUE WALL | 2020-04-02 |
20200101211 | DIALYSATE FOR HEMODIALYSIS | 2020-04-02 |
20200101212 | ELECTRICAL PLUG FOR A DIALYSIS MACHINE | 2020-04-02 |
20200101213 | PERITONEAL DIALYSIS SOLUTION | 2020-04-02 |
20200101214 | SYSTEMS AND METHODS FOR EXTRACORPOREAL BLOOD MODIFICATION | 2020-04-02 |
20200101215 | PRESSURE MEASURING DEVICE AND EXTRACORPOREAL CIRCULATOR | 2020-04-02 |
20200101216 | DIALYSIS ACCESS | 2020-04-02 |
20200101217 | ENEMA DEVICE FOR WASHING LARGE INTESTINE | 2020-04-02 |
20200101218 | THERAPEUTIC PRODUCT DELIVERY DEVICE | 2020-04-02 |
20200101219 | Injection Device | 2020-04-02 |
20200101220 | MANAGEMENT OF CARE AREA TRANSITIONS OF INTRAVENOUS INFUSIONS | 2020-04-02 |